OHSU Study shows 63% drop in uninsured Oregonians

A study released September 18 shows that the number of uninsured Oregonians fell by 63 percent from June 30, 2013 to June 30, 2014. Researchers at OHSU and the Oregon Health Authority  assessed whether policy changes associated with the Affordable Care Act changed the number of uninsured Oregonians. Support for the study was provided by the Oregon Health Authority and by the Robert Wood Johnson Foundation’s State Health Reform Assistance Network.

James D. Ross, Ph.D., DAF: Aortic Occlusion Systems: Potentially Powerful Tools, Significant Risk? – 9/25

James D. Ross, Ph.D., DAF, Air Force Medical Service and Director of the Air Force Trauma and Resuscitation Research Program, Joint Base San Antonio – Lackland, will present his talk, “Aortic Occlusion Systems: Potentially Powerful Tools, Significant Risk?” on Thursday, Sept 25th, 4 p.m., Mackenzie Hall 3198.

Dr. Ross is a translational science expert in trauma and hemorrhage. He joined the Naval Medical Research Unit, San Antonio in 2010 as a Senior Research Physiologist for Combat Casualty Care and eventually became the Deputy Department Head of the CCC Research Program. In 2012, Dr. Ross was selected as the GS-15 Director of Trauma and Clinical Care Research for the 59th Medical Wing at the Wilford Hall Ambulatory Surgical Center and the Battlefield Health and Trauma Research Institute.

HHMI International Student Research Fellowships; internal LOI due Oct. 17

The Howard Hughes Medical Institute (HHMI) seeks applications from outstanding international pre-doctoral students studying in the U.S. who are ineligible for fellowships or training grants through U.S. federal agencies. The HHMI International Student Research Fellowship program funds three-year fellowships for international graduate students worth over $30,000 per year. The fellowships are intended to support years three, four, and five of a Ph.D. program. HHMI seeks fellows in the following biomedical-related fields: biology, chemistry, physics, math, computer science, engineering, plant biology, and interdisciplinary research.

To be eligible, applicants should currently be in the second (or third) year of graduate study, have entered a laboratory in which they will conduct their dissertation research, and not be citizens, non-citizen nationals, or permanent residents of the U.S.
Please note
This opportunity requires internal coordination since OHSU may only submit a limited number of applications . If you intend to apply, please complete a limited submission form before October 17, 2014.

Look for other current funding opportunities.

Research Administration classes this fall: RDA 101

Research Administration Training & Education (RATE) is offering a number of great classes in the next few months for Research Administrators and others who support Research at OHSU. See the schedule of classes here. There are still spots available in this week’s class:

Wednesday, September 24  RDA 101: Introduction to Research Administration

9:30 a.m. to 11:30 a.m., Bancroft Building Community Room

Whether you’re new to OHSU Research or have been around but would like to put some faces to names, or fill in gaps, join us as we take a big-picture look at Research Administration. Meet RDA unit leaders, tour valuable web resources, and say hello to your contacts in SPA, RGC, IRB, etc.

Contact Margaret Gardner to reserve your seat or for any other questions about this.

IRB Notes eIRB Helpdesk: Top Tips for IRB Submissions

1. I need to add or remove a staff member on my eIRB study. What’s the best way to do this?

You should submit staff changes independent of other changes to your study. Normally, staff-only modifications can be turned around within 24 hours, allowing your change to take effect quickly. If you pair this change with other items, the staff has to wait for the approval of the entire modification.

2. I am trying to add someone to my eIRB study, but I am not finding them in the search. What gives?

Chances are one of two things has happened. First, double check that the person has registered for the eIRB. Simply taking the Big Brain courses doesn’t create an eIRB account. If someone needs to register, they can find the “Registration” link at the bottom left of the eIRB login page. If they’ve already registered for the eIRB, check that you are spelling their name correctly. The eIRB is connected to the HR database, so you must use the person’s name as it appears in HR’s records.

3. I am adding someone to my eIRB study, and I am getting an error message that they are not compliant with the required Big Brain trainings and / or Conflict of Interest. I think they have two Big Brain accounts; what do I do?

You can handle this one of two ways. First, you can email your request, and the person’s full name, to oioeduc@ohsu.edu. Second, you can call us to have the person’s account updated. Once the multiple accounts are merged, the system updates overnight, and you’ll be ready to submit!

IRB Brown Bag: STudents As ResearcherS: STARS in the IRB Sky

Brown BagSTudents As ResearcherS: STARS in the IRB Sky
Student Research
Lynn Marshall – IRB Vice Chair
Thursday September 25th, 2014
11:30 AM – 12:30 PM
UHS 8B60
IRB Vice Chair Lynn Marshall will lead a space walk through of the basics of submitting your research to the Institutional Review Board (IRB) for review. She will cover our online submission system, the documents you need to prepare, what elements should be in the documents, and how to avoid common omissions that delay approval.

Deadline extended: Graduate Research Fellowship applications for Neurobiology of Disease due Sept. 26

The OHSU Brain Institute announces the 2014 Neurobiology of Disease Fellowship Award Program (this award includes base stipend plus $2,000) that can support graduate students (Ph.D. or M.D./Ph.D.) pursuing research relevant to the neurobiology of disease. Applications will be judged on the basis of scientific merit, novelty, relevance of the research to the neurobiology of disease, the commitment of the student to ongoing research on the neurobiology of disease, and the mentor’s qualifications.

The deadline to apply is September 26, 2014

Eligibility requirements:

  • Student must have completed at least one year of Ph.D. training at OHSU and be enrolled full-time as a Ph.D. student during the proposed year of fellowship support.  Preference will be given to 3rd and 4th year graduate students and students who have not previously received an OHSU Brain Institute Graduate Student Fellowship.
  • The student’s research interests must be relevant to the neurobiology of disease.
  • Student must have identified a mentor who has agreed to supervise the dissertation and provide support for the student’s research.
  • Student must be in good academic standing with a GPA ≥ 3.0.

Graduate students interested in applying for these fellowships should submit the following as a single PDF document:

  • A brief description of the proposed research (three pages maximum, not including references). This should include a clearly stated hypothesis, specific aims, impact, significance, preliminary data and experimental design. Font should be Arial or New Times and be no smaller than 11 point. Margins should be 1”. Applications using smaller fonts or margins will not be considered.
  • A description (1/2 page) of student’s long term career goals
  • Student’s curriculum vitae
  • A letter from the mentor indicating the support available for the graduate student and the proposed research
  • Mentor’s biographical sketch and research support (NIH format)

To submit applications, email applicaiton materials to Ashley Uchtman, Program Coordinator, OHSU Brain Institute.

Gates Foundation Grand Challenges Explorations proposals due Nov. 12

The Bill & Melinda Gates Foundation has announced its research topics for the 14th round of its Grand Challenges Explorations grant program. This program is intended to foster unconventional ideas that could transform health and agricultural development in the world’s poorest countries. Grants of up to $100,000 are available to applicants at any experience level; in any discipline; and from any organization, including colleges and universities, government laboratories, research institutions, non-profit organizations and for-profit companies. Projects will have one opportunity to apply for a follow-on Phase II grant of up to $1 million. The topics in this round are:

Applications are due November 12, 2014.

See other active funding opportunities in this week’s Funding Alerts.

Fall Vollum Writing Program starts Sept. 24

The Vollum Writing Program is a 6-week professional science writing course open to OHSU graduate students, postdoctoral fellows, and junior faculty.

This class uses short lectures, class discussion, and workshop-style writing assignments to help researchers learn to write better papers and grants. Topics include:

  • The basic elements of good scientific writing style, including sentence and document structure;
  • Insight into scientific conventions regarding grammar, punctuation, and usage;
  • Strategies for revising;
  • Dealing with writer’s block and time management;
  • Best practices for writing introductions, results, discussions, and grant proposals.

The class runs for six weeks, from 9:30 a.m. to 12 p.m. on Wednesdays, beginning September 24, 2014. Six individual tutorials with the instructor are included. There are no prerequisites for this noncredit, professional development course, but you should not take the class unless you have enough data to write about.

The course carries a fee of $500 per student (unless you are in a Vollum lab or part of select graduate Ph.D. programs). Questions? Contact Taylor St. Clair.

Register for the Fall Vollum Writing Program.

OHSU startup Orexigen earns FDA approval

The office of Technology Transfer and Business Development is happy to announce that a drug from  Orexigen Therapeutics Inc., called Contrave, has been approved by the FDA. This drug helps with weight management, along with a reduced-calorie diet and increased physical activity, in adults with an initial body mass index of 30 kg/m2 or greater (obese), or 27 kg/m2 or greater (overweight) who also have at least one weight-related comorbid condition.

Contrave has two components: naltrexone, an opioid antagonist, and bupropion, a relatively weak inhibitor of the neuronal reuptake of dopamine and norepinephrine. Nonclinical studies suggest that naltrexone and bupropion have effects on two separate areas of the brain involved in the regulation of food intake: the hypothalamus, which regulates appetite, and the dopamine circuit,  which serves as a reward system.

Orexigen is an OHSU startup company.  The FDA’s approval of Contrave represents a significant milestone for both Orexigen and OHSU.  Sales through Orexigen’s North American partner, Takeda Pharmaceuticals, are set to begin this fall.

Welcome to the Research News Blog

Welcome to the Research News Blog

OHSU Research News is your portal to information about all things research at Oregon Health & Science University. Visit often for updates on events, discoveries, and important funding information.

Read more

Participation Guidelines

Remember: information you share here is public; it isn't medical advice. Need advice or treatment? Contact your healthcare provider directly. Read our Terms of Use and this disclaimer for details.